101 related articles for article (PubMed ID: 30474304)
1. TRB-J1 usage, in combination with the HLA-A*01:01 allele, represents an apparent survival advantage for uterine corpus endometrial carcinoma: Comparisons with microscopic assessments of lymphocyte infiltrates.
Clark KR; Tong WL; Callahan BM; Yavorski JM; Tu YN; Blanck G
Int J Immunogenet; 2019 Feb; 46(1):31-37. PubMed ID: 30474304
[TBL] [Abstract][Full Text] [Related]
2. TRBV and TRBJ usage, when paired with specific HLA alleles, associates with distinct head and neck cancer survival rates.
Arndt MF; Koohestani DM; Chobrutskiy BI; Mihyu MM; Diaz M; Gozlan EC; Yeagley M; Zaman S; Roca AM; Blanck G
Hum Immunol; 2020 Dec; 81(12):692-696. PubMed ID: 32950267
[TBL] [Abstract][Full Text] [Related]
3. Immune receptor recombinations from breast cancer exome files, independently and in combination with specific HLA alleles, correlate with better survival rates.
Tong WL; Callahan BM; Tu YN; Zaman S; Chobrutskiy BI; Blanck G
Breast Cancer Res Treat; 2019 Jan; 173(1):167-177. PubMed ID: 30229447
[TBL] [Abstract][Full Text] [Related]
4. T-cell receptor V and J usage paired with specific HLA alleles associates with distinct cervical cancer survival rates.
Roca AM; Chobrutskiy BI; Callahan BM; Blanck G
Hum Immunol; 2019 Apr; 80(4):237-242. PubMed ID: 30684568
[TBL] [Abstract][Full Text] [Related]
5. Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade.
Chobrutskiy BI; Zaman S; Tong WL; Diviney A; Blanck G
J Neurooncol; 2018 Dec; 140(3):697-704. PubMed ID: 30382482
[TBL] [Abstract][Full Text] [Related]
6. T-cell receptor-β V and J usage, in combination with particular HLA class I and class II alleles, correlates with cancer survival patterns.
Callahan BM; Yavorski JM; Tu YN; Tong WL; Kinskey JC; Clark KR; Fawcett TJ; Blanck G
Cancer Immunol Immunother; 2018 Jun; 67(6):885-892. PubMed ID: 29508024
[TBL] [Abstract][Full Text] [Related]
7. B-cell Receptor Recombinations in Lung Adenocarcinoma Exome Files Correlate With a Higher Overall Survival Rate.
Tu YN; Tong WL; Callahan BM; Chobrutskiy BI; Blanck G
Anticancer Res; 2020 Apr; 40(4):2043-2051. PubMed ID: 32234895
[TBL] [Abstract][Full Text] [Related]
8. TcR-α recombinations in renal cell carcinoma exome files correlate with an intermediate level of T-cell exhaustion biomarkers.
Mai AT; Tong WL; Tu YN; Blanck G
Int Immunol; 2018 Feb; 30(1):35-40. PubMed ID: 29361059
[TBL] [Abstract][Full Text] [Related]
9. Assessing microenvironment immunogenicity using tumor specimen exomes: Co-detection of TcR-α/β V(D)J recombinations correlates with PD-1 expression.
Tu YN; Tong WL; Samy MD; Yavorski JM; Kim M; Blanck G
Int J Cancer; 2017 Jun; 140(11):2568-2576. PubMed ID: 28256716
[TBL] [Abstract][Full Text] [Related]
10. A comparison of immune receptor recombination databases sourced from tumour exome or RNAseq files: Verifications of immunological distinctions between primary and metastatic melanoma.
Patel DN; Yeagley M; Arturo JF; Falasiri S; Chobrutskiy BI; Gozlan EC; Blanck G
Int J Immunogenet; 2021 Oct; 48(5):409-418. PubMed ID: 34298587
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of T cell clonality and expression levels of immune-related genes in endometrial cancer.
Ikeda Y; Kiyotani K; Yew PY; Sato S; Imai Y; Yamaguchi R; Miyano S; Fujiwara K; Hasegawa K; Nakamura Y
Oncol Rep; 2017 May; 37(5):2603-2610. PubMed ID: 28358435
[TBL] [Abstract][Full Text] [Related]
12. T cell receptor-β J usage, in combination with particular HLA class II alleles, correlates with better cancer survival rates.
Callahan BM; Tong WL; Blanck G
Immunol Res; 2018 Apr; 66(2):219-223. PubMed ID: 29594966
[TBL] [Abstract][Full Text] [Related]
13. Specific HLA alleles, paired with TCR V- and J-gene segment usage, link to distinct multiple myeloma survival rates.
Huda TI; Mihyu M; Gozlan EC; Arndt MF; Diaz MJ; Zaman S; Chobrutskiy BI; Blanck G
Leuk Lymphoma; 2021 Jul; 62(7):1711-1720. PubMed ID: 33622167
[TBL] [Abstract][Full Text] [Related]
14. Lung tumor exome files with T-cell receptor recombinations: a mouse model of T-cell infiltrates reflecting mutation burdens.
Tu YN; Tong WL; Fawcett TJ; Blanck G
Lab Invest; 2017 Dec; 97(12):1516-1520. PubMed ID: 28805806
[TBL] [Abstract][Full Text] [Related]
15. TRB CDR3-cancer testis antigen chemical complementarity scoring for identifying productive immune responses in renal cell carcinoma.
Hudock TR; Barker VR; Manley BJ; Chobrutskiy A; Chobrutskiy BI; Diaz MJ; Song JJ; Blanck G
Cancer Biomark; 2023; 38(1):103-110. PubMed ID: 37545223
[TBL] [Abstract][Full Text] [Related]
16. Recovery of Immunoglobulin VJ Recombinations from Pancreatic Cancer Exome Files Strongly Correlates with Reduced Survival.
Kinskey JC; Tu YN; Tong WL; Yavorski JM; Blanck G
Cancer Microenviron; 2018 Jun; 11(1):51-59. PubMed ID: 29404962
[TBL] [Abstract][Full Text] [Related]
17. A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma.
Zhou M; Zhang Z; Zhao H; Bao S; Sun J
BMC Cancer; 2018 Jan; 18(1):39. PubMed ID: 29304762
[TBL] [Abstract][Full Text] [Related]
18. LYL1 gene amplification predicts poor survival of patients with uterine corpus endometrial carcinoma: analysis of the Cancer genome atlas data.
Kim SI; Lee JW; Lee N; Lee M; Kim HS; Chung HH; Kim JW; Park NH; Song YS; Seo JS
BMC Cancer; 2018 May; 18(1):494. PubMed ID: 29716549
[TBL] [Abstract][Full Text] [Related]
19. Alteration of tumor associated neutrophils by PIK3CA expression in endometrial carcinoma from TCGA data.
Pan Y; Jia LP; Liu Y; Han Y; Deng Q
J Ovarian Res; 2019 Aug; 12(1):81. PubMed ID: 31472672
[TBL] [Abstract][Full Text] [Related]
20. T cell receptor gene recombinations in human tumor specimen exome files: detection of T cell receptor-β VDJ recombinations associates with a favorable oncologic outcome for bladder cancer.
Samy MD; Tong WL; Yavorski JM; Sexton WJ; Blanck G
Cancer Immunol Immunother; 2017 Mar; 66(3):403-410. PubMed ID: 27995306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]